What's new

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 4, Status: Authorised

Mar 11, 2025 - 14:31
 0
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

New study demonstrates genAI value in mental health care

Next Article

SPOR and XEVMPD status update webinar, Broadcast, from 8 October 2025, 10:00 (CE...

Related Posts

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 5 December 2024, 09:30 (CET) to 5 December 2024, 13:30 (CET)

Meeting of the Medicine Shortages Single Point of Conta...

Feb 10, 2025  0

Veterinary medicines European public assessment report (EPAR): Bluevac-3, bluetongue virus vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report ...

Mar 5, 2025  0

Superseded assessment report on Urtica dioica L., Urtic...

Mar 12, 2025  0